Nitrosylated neuropeptides
Patent 5612314 Issued on March 18, 1997. Estimated Expiration Date: 
April 21, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
April 21, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesS-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof Treatments for male sexual dysfunction Method and agents for control and management of labor during pregnancy Patent #: 5508045 InventorsAssigneeApplicationNo. 426935 filed on 04/21/1995US Classes:514/13, 16 to 24 peptide repeating units in known peptide chain524/14, At least one solid polymer or SICP derived from at least one nonethylenic reactant524/15, Vegetable shell, hull, or cob ingredient, e.g., nut shells, pits, etc.524/16, Bark or cork524/17, Protein or biologically active polypeptide DNRM excluding wheat flour or natural cereals which may contain protein ingredient530/324, 25 or more amino acid residues in defined sequence530/325, 24 amino acid residues in defined sequence530/326, 15 to 23 amino acid residues in defined sequence530/327, 11 to 14 amino acid residues in defined sequence530/328, 8 to 10 amino acid residues in defined sequence530/3296 to 7 amino acid residues in defined sequenceExaminersPrimary: Cain, Edward J.Attorney, Agent or FirmInternational ClassA61K 037/00AbstractNeuropeptides, particularly vasoactive intestinal peptide(VIP) and fragments, mutations and derivatives thereof that have corresponding activities to which have been directly or indirectly linked at least one NO or NO2 group, and their uses, including the relaxation of smooth muscle in several tissues, including vascular smooth muscle (e.g., aorta) and nonvascular smooth muscle (e.g. trachea, sphincter of Oddi, gastrointestinal smooth muscle and corpus cavernosum smooth muscle), and particularly also for the diagnosis and treatment of human male impotence.Field of Search16 to 24 peptide repeating units in known peptide chain25 or more amino acid residues in defined sequence 24 amino acid residues in defined sequence 15 to 23 amino acid residues in defined sequence 11 to 14 amino acid residues in defined sequence 8 to 10 amino acid residues in defined sequence 6 to 7 amino acid residues in defined sequence At least one solid polymer or SICP derived from at least one nonethylenic reactant Vegetable shell, hull, or cob ingredient, e.g., nut shells, pits, etc. Bark or cork Protein or biologically active polypeptide DNRM excluding wheat flour or natural cereals which may contain protein ingredient |
| ||||||||||||||
